Epigenetic modifiers: activities in renal cell carcinoma.

Area of Science:

• Oncology
• Epigenetics
• Genetics

Background:

• Renal cell carcinoma (RCC) is a heterogeneous cancer.
• High-throughput sequencing identified mutations in chromatin modifier genes in RCC.
• Chromatin modifiers play crucial roles in epigenetic regulation.

Purpose of the Study:

• To investigate the biological activities of chromatin modifiers in RCC tumorigenesis.
• To explore therapeutic opportunities based on chromatin modifier functions in RCC.

Main Methods:

• Analysis of high-throughput sequencing data.
• Review of current research on chromatin modifier functions.

Main Results:

• Chromatin modifiers regulate histone modifications, nucleosome organization, DNA repair, and splicing.
• These modifiers also have non-canonical roles in cytoskeletal regulation, impacting genomic stability.
• Mutations in genes like PBRM1, SETD2, BAP1, KDM5C, KDM6A, and MLL2 are implicated in RCC.

Conclusions:

• Understanding chromatin modifier functions in RCC is crucial for developing targeted therapies.
• Elucidating the roles of these epigenetic regulators presents significant therapeutic potential for RCC patients.